Compare RNP & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNP | QDEL |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 2022 |
| Metric | RNP | QDEL |
|---|---|---|
| Price | $21.06 | $12.97 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 76.1K | ★ 2.1M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 7.94% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.27 | $9.92 |
| 52 Week High | $22.99 | $35.58 |
| Indicator | RNP | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 57.12 | 54.42 |
| Support Level | $20.44 | $10.86 |
| Resistance Level | $21.24 | $17.78 |
| Average True Range (ATR) | 0.28 | 0.88 |
| MACD | 0.01 | 0.40 |
| Stochastic Oscillator | 62.10 | 83.45 |
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.